Epidemiology of hepatitis e in low- and middle-income countries of Asia and Africa

Brittany Kmush, Thomas Wierzba, Lisa Krain, Kenrad Nelson, Alain B. Labrique

Research output: Contribution to journalArticlepeer-review

69 Scopus citations


Hepatitis E is an acute, viral hepatitis primarily transmitted through the fecal-oral route. The first major epidemic of hepatitis E virus (HEV) was reported in 1955 in Delhi, India. Since that time, numerous epidemics have been reported across the low- and middle-income countries in Asia and Africa. Even in the absence of large-scale outbreaks, hepatitis E is an important cause of clinical hepatitis. Serologic studies across Asia and Africa show a high prevalence of anti-HEV antibodies. Interest in hepatitis E has increased over the last two decades. However, there are many unanswered questions about the epidemiology of hepatitis E, including a low clinical illness rate in children and the high case fatality rate in pregnant women. Widespread usage of a hepatitis E vaccine may serve to relieve the burden of HEV disease in low- and middle-income countries in Africa and Asia.

Original languageEnglish (US)
Pages (from-to)15-29
Number of pages15
JournalSeminars in Liver Disease
Issue number1
StatePublished - 2013


  • Africa
  • Asia
  • HEV
  • LMIC
  • hepatitis E

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Epidemiology of hepatitis e in low- and middle-income countries of Asia and Africa'. Together they form a unique fingerprint.

Cite this